Psoriasis
Not recruitingStudy on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis
Hungary- Participants:18–64 years · 65+ years
- Substances:Ly4100511
- Sponsor:DICE Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary122 clinical trials in Szolnok, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on plaque psoriasis and atopic dermatitis treatments, evaluating novel therapies for moderate to severe cases.
Multiple trials testing new biological treatments and long-term safety assessments for chronic skin conditions.
Comprehensive research into various cancer types, with particular focus on lung cancer treatments and innovative immunotherapy approaches.
Investigation of novel combination therapies and targeted treatments for advanced stage cancers.
Studies examining treatments for heart failure prevention and management of cardiovascular conditions.
Innovative approaches to reducing cardiovascular risks and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.